Concepedia

Jorge Fortanet

JF

3

Publications

448

Citations

3

H-Index

2016

Active since

Affiliations

Novartis (United States)(Current)

Jorge Fortanet is an author at Novartis (United States) specializing in drug discovery, natural sciences, and medicine.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesBiochemistryCell BiologyCell SignalingChemical BiologyMedicinal ChemistrySignal Transduction

Publications per year

2016–2019

3

Publications

3

Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor

Jorge Fortanet, Christine Hiu-Tung Chen, Ying-Nan P. Chen et al. · Journal of Medicinal Chemistry · 2016 · 284 citations · Full text

Allosteric Inhibition, Drug Target, Shp2 Inhibition +20

6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

Medicinal Chemistry, Allosteric Shp2 Inhibitors, Drug Target +15

Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors

Jeffrey T. Bagdanoff, Zhouliang Chen, Michael Acker et al. · Journal of Medicinal Chemistry · 2019 · 79 citations · Full text

Medicinal Chemistry, Signaling Pathway, Receptor Tyrosine Kinase +16

Rows per page

1–3 of 3